Eintrag weiter verarbeiten
Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway
Gespeichert in:
| Zeitschriftentitel: | Toxins |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , , , , |
| In: | Toxins, 11, 2019, 4, S. 185 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
MDPI AG
|
| Schlagwörter: |
| author_facet |
Chang, Chih-Hsiang Chen, Mei-Chih Chiu, Te-Huan Li, Yu-Hsuan Yu, Wan-Chen Liao, Wan-Ling Oner, Muhammet Yu, Chang-Tze Wu, Chun-Chi Yang, Tsung-Ying Teng, Chieh-Lin Chiu, Kun-Yuan Chen, Kun-Chien Wang, Hsin-Yi Yue, Chia-Herng Lai, Chih-Ho Hsieh, Jer-Tsong Lin, Ho Chang, Chih-Hsiang Chen, Mei-Chih Chiu, Te-Huan Li, Yu-Hsuan Yu, Wan-Chen Liao, Wan-Ling Oner, Muhammet Yu, Chang-Tze Wu, Chun-Chi Yang, Tsung-Ying Teng, Chieh-Lin Chiu, Kun-Yuan Chen, Kun-Chien Wang, Hsin-Yi Yue, Chia-Herng Lai, Chih-Ho Hsieh, Jer-Tsong Lin, Ho |
|---|---|
| author |
Chang, Chih-Hsiang Chen, Mei-Chih Chiu, Te-Huan Li, Yu-Hsuan Yu, Wan-Chen Liao, Wan-Ling Oner, Muhammet Yu, Chang-Tze Wu, Chun-Chi Yang, Tsung-Ying Teng, Chieh-Lin Chiu, Kun-Yuan Chen, Kun-Chien Wang, Hsin-Yi Yue, Chia-Herng Lai, Chih-Ho Hsieh, Jer-Tsong Lin, Ho |
| spellingShingle |
Chang, Chih-Hsiang Chen, Mei-Chih Chiu, Te-Huan Li, Yu-Hsuan Yu, Wan-Chen Liao, Wan-Ling Oner, Muhammet Yu, Chang-Tze Wu, Chun-Chi Yang, Tsung-Ying Teng, Chieh-Lin Chiu, Kun-Yuan Chen, Kun-Chien Wang, Hsin-Yi Yue, Chia-Herng Lai, Chih-Ho Hsieh, Jer-Tsong Lin, Ho Toxins Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway Health, Toxicology and Mutagenesis Toxicology |
| author_sort |
chang, chih-hsiang |
| spelling |
Chang, Chih-Hsiang Chen, Mei-Chih Chiu, Te-Huan Li, Yu-Hsuan Yu, Wan-Chen Liao, Wan-Ling Oner, Muhammet Yu, Chang-Tze Wu, Chun-Chi Yang, Tsung-Ying Teng, Chieh-Lin Chiu, Kun-Yuan Chen, Kun-Chien Wang, Hsin-Yi Yue, Chia-Herng Lai, Chih-Ho Hsieh, Jer-Tsong Lin, Ho 2072-6651 MDPI AG Health, Toxicology and Mutagenesis Toxicology http://dx.doi.org/10.3390/toxins11040185 <jats:p>Arecoline is the primary alkaloid in betel nuts, which are known as a risk factor for oral submucosal fibrosis and oral cancer. Lung cancer is a severe type of carcinoma with high cell motility that is difficult to treat. However, the detailed mechanisms of the correlation between Arecoline and lung cancer are not fully understood. Here, we investigated the effect of Arecoline on migration in lung cancer cell lines and its potential mechanism through the muscarinic acetylcholine receptor 3 (mAChR3)-triggered EGFR/Src/FAK pathway. Our results indicate that different concentrations of Arecoline treatment (10 µM, 20 µM, and 40 µM) significantly increased the cell migration ability in A549 and CL1-0 cells and promoted the formation of the filamentous actin (F-actin) cytoskeleton, which is a crucial element for cell migration. However, migration of H460, CL1-5, and H520 cell lines, which have a higher migration ability, was not affected by Arecoline treatment. The EGFR/c-Src/Fak pathway, which is responsible for cell migration, was activated by Arecoline treatment, and a decreased expression level of E-cadherin, which is an epithelial marker, was observed in Arecoline-treated cell lines. Blockade of the EGFR/c-Src/Fak pathway with the inhibitors of EGFR (Gefitinib) or c-Src (Dasatinib) significantly prevented Arecoline-promoted migration in A549 cells. Gefitinib or Dasatinib treatment significantly disrupted the Arecoline-induced localization of phospho-Y576-Fak during focal adhesion in A549 cells. Interestingly, Arecoline-promoted migration in A549 cells was blocked by a specific mAChR3 inhibitor (4-DAMP) or a neutralizing antibody of matrix metalloproteinase (MMP7 or Matrilysin). Taken together, our findings suggest that mAChR3 might play an essential role in Arecoline-promoted EGFR/c-Src/Fak activation and migration in an A549 lung cancer cell line.</jats:p> Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway Toxins |
| doi_str_mv |
10.3390/toxins11040185 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC90b3hpbnMxMTA0MDE4NQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC90b3hpbnMxMTA0MDE4NQ |
| institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
| imprint |
MDPI AG, 2019 |
| imprint_str_mv |
MDPI AG, 2019 |
| issn |
2072-6651 |
| issn_str_mv |
2072-6651 |
| language |
English |
| mega_collection |
MDPI AG (CrossRef) |
| match_str |
chang2019arecolinepromotesmigrationofa549lungcancercellsthroughactivatingtheegfrsrcfakpathway |
| publishDateSort |
2019 |
| publisher |
MDPI AG |
| recordtype |
ai |
| record_format |
ai |
| series |
Toxins |
| source_id |
49 |
| title |
Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_unstemmed |
Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_full |
Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_fullStr |
Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_full_unstemmed |
Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_short |
Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_sort |
arecoline promotes migration of a549 lung cancer cells through activating the egfr/src/fak pathway |
| topic |
Health, Toxicology and Mutagenesis Toxicology |
| url |
http://dx.doi.org/10.3390/toxins11040185 |
| publishDate |
2019 |
| physical |
185 |
| description |
<jats:p>Arecoline is the primary alkaloid in betel nuts, which are known as a risk factor for oral submucosal fibrosis and oral cancer. Lung cancer is a severe type of carcinoma with high cell motility that is difficult to treat. However, the detailed mechanisms of the correlation between Arecoline and lung cancer are not fully understood. Here, we investigated the effect of Arecoline on migration in lung cancer cell lines and its potential mechanism through the muscarinic acetylcholine receptor 3 (mAChR3)-triggered EGFR/Src/FAK pathway. Our results indicate that different concentrations of Arecoline treatment (10 µM, 20 µM, and 40 µM) significantly increased the cell migration ability in A549 and CL1-0 cells and promoted the formation of the filamentous actin (F-actin) cytoskeleton, which is a crucial element for cell migration. However, migration of H460, CL1-5, and H520 cell lines, which have a higher migration ability, was not affected by Arecoline treatment. The EGFR/c-Src/Fak pathway, which is responsible for cell migration, was activated by Arecoline treatment, and a decreased expression level of E-cadherin, which is an epithelial marker, was observed in Arecoline-treated cell lines. Blockade of the EGFR/c-Src/Fak pathway with the inhibitors of EGFR (Gefitinib) or c-Src (Dasatinib) significantly prevented Arecoline-promoted migration in A549 cells. Gefitinib or Dasatinib treatment significantly disrupted the Arecoline-induced localization of phospho-Y576-Fak during focal adhesion in A549 cells. Interestingly, Arecoline-promoted migration in A549 cells was blocked by a specific mAChR3 inhibitor (4-DAMP) or a neutralizing antibody of matrix metalloproteinase (MMP7 or Matrilysin). Taken together, our findings suggest that mAChR3 might play an essential role in Arecoline-promoted EGFR/c-Src/Fak activation and migration in an A549 lung cancer cell line.</jats:p> |
| container_issue |
4 |
| container_start_page |
0 |
| container_title |
Toxins |
| container_volume |
11 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792347944016412680 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T18:03:19.011Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Arecoline+Promotes+Migration+of+A549+Lung+Cancer+Cells+through+Activating+the+EGFR%2FSrc%2FFAK+Pathway&rft.date=2019-03-28&genre=article&issn=2072-6651&volume=11&issue=4&pages=185&jtitle=Toxins&atitle=Arecoline+Promotes+Migration+of+A549+Lung+Cancer+Cells+through+Activating+the+EGFR%2FSrc%2FFAK+Pathway&aulast=Lin&aufirst=Ho&rft_id=info%3Adoi%2F10.3390%2Ftoxins11040185&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792347944016412680 |
| author | Chang, Chih-Hsiang, Chen, Mei-Chih, Chiu, Te-Huan, Li, Yu-Hsuan, Yu, Wan-Chen, Liao, Wan-Ling, Oner, Muhammet, Yu, Chang-Tze, Wu, Chun-Chi, Yang, Tsung-Ying, Teng, Chieh-Lin, Chiu, Kun-Yuan, Chen, Kun-Chien, Wang, Hsin-Yi, Yue, Chia-Herng, Lai, Chih-Ho, Hsieh, Jer-Tsong, Lin, Ho |
| author_facet | Chang, Chih-Hsiang, Chen, Mei-Chih, Chiu, Te-Huan, Li, Yu-Hsuan, Yu, Wan-Chen, Liao, Wan-Ling, Oner, Muhammet, Yu, Chang-Tze, Wu, Chun-Chi, Yang, Tsung-Ying, Teng, Chieh-Lin, Chiu, Kun-Yuan, Chen, Kun-Chien, Wang, Hsin-Yi, Yue, Chia-Herng, Lai, Chih-Ho, Hsieh, Jer-Tsong, Lin, Ho, Chang, Chih-Hsiang, Chen, Mei-Chih, Chiu, Te-Huan, Li, Yu-Hsuan, Yu, Wan-Chen, Liao, Wan-Ling, Oner, Muhammet, Yu, Chang-Tze, Wu, Chun-Chi, Yang, Tsung-Ying, Teng, Chieh-Lin, Chiu, Kun-Yuan, Chen, Kun-Chien, Wang, Hsin-Yi, Yue, Chia-Herng, Lai, Chih-Ho, Hsieh, Jer-Tsong, Lin, Ho |
| author_sort | chang, chih-hsiang |
| container_issue | 4 |
| container_start_page | 0 |
| container_title | Toxins |
| container_volume | 11 |
| description | <jats:p>Arecoline is the primary alkaloid in betel nuts, which are known as a risk factor for oral submucosal fibrosis and oral cancer. Lung cancer is a severe type of carcinoma with high cell motility that is difficult to treat. However, the detailed mechanisms of the correlation between Arecoline and lung cancer are not fully understood. Here, we investigated the effect of Arecoline on migration in lung cancer cell lines and its potential mechanism through the muscarinic acetylcholine receptor 3 (mAChR3)-triggered EGFR/Src/FAK pathway. Our results indicate that different concentrations of Arecoline treatment (10 µM, 20 µM, and 40 µM) significantly increased the cell migration ability in A549 and CL1-0 cells and promoted the formation of the filamentous actin (F-actin) cytoskeleton, which is a crucial element for cell migration. However, migration of H460, CL1-5, and H520 cell lines, which have a higher migration ability, was not affected by Arecoline treatment. The EGFR/c-Src/Fak pathway, which is responsible for cell migration, was activated by Arecoline treatment, and a decreased expression level of E-cadherin, which is an epithelial marker, was observed in Arecoline-treated cell lines. Blockade of the EGFR/c-Src/Fak pathway with the inhibitors of EGFR (Gefitinib) or c-Src (Dasatinib) significantly prevented Arecoline-promoted migration in A549 cells. Gefitinib or Dasatinib treatment significantly disrupted the Arecoline-induced localization of phospho-Y576-Fak during focal adhesion in A549 cells. Interestingly, Arecoline-promoted migration in A549 cells was blocked by a specific mAChR3 inhibitor (4-DAMP) or a neutralizing antibody of matrix metalloproteinase (MMP7 or Matrilysin). Taken together, our findings suggest that mAChR3 might play an essential role in Arecoline-promoted EGFR/c-Src/Fak activation and migration in an A549 lung cancer cell line.</jats:p> |
| doi_str_mv | 10.3390/toxins11040185 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC90b3hpbnMxMTA0MDE4NQ |
| imprint | MDPI AG, 2019 |
| imprint_str_mv | MDPI AG, 2019 |
| institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
| issn | 2072-6651 |
| issn_str_mv | 2072-6651 |
| language | English |
| last_indexed | 2024-03-01T18:03:19.011Z |
| match_str | chang2019arecolinepromotesmigrationofa549lungcancercellsthroughactivatingtheegfrsrcfakpathway |
| mega_collection | MDPI AG (CrossRef) |
| physical | 185 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | MDPI AG |
| record_format | ai |
| recordtype | ai |
| series | Toxins |
| source_id | 49 |
| spelling | Chang, Chih-Hsiang Chen, Mei-Chih Chiu, Te-Huan Li, Yu-Hsuan Yu, Wan-Chen Liao, Wan-Ling Oner, Muhammet Yu, Chang-Tze Wu, Chun-Chi Yang, Tsung-Ying Teng, Chieh-Lin Chiu, Kun-Yuan Chen, Kun-Chien Wang, Hsin-Yi Yue, Chia-Herng Lai, Chih-Ho Hsieh, Jer-Tsong Lin, Ho 2072-6651 MDPI AG Health, Toxicology and Mutagenesis Toxicology http://dx.doi.org/10.3390/toxins11040185 <jats:p>Arecoline is the primary alkaloid in betel nuts, which are known as a risk factor for oral submucosal fibrosis and oral cancer. Lung cancer is a severe type of carcinoma with high cell motility that is difficult to treat. However, the detailed mechanisms of the correlation between Arecoline and lung cancer are not fully understood. Here, we investigated the effect of Arecoline on migration in lung cancer cell lines and its potential mechanism through the muscarinic acetylcholine receptor 3 (mAChR3)-triggered EGFR/Src/FAK pathway. Our results indicate that different concentrations of Arecoline treatment (10 µM, 20 µM, and 40 µM) significantly increased the cell migration ability in A549 and CL1-0 cells and promoted the formation of the filamentous actin (F-actin) cytoskeleton, which is a crucial element for cell migration. However, migration of H460, CL1-5, and H520 cell lines, which have a higher migration ability, was not affected by Arecoline treatment. The EGFR/c-Src/Fak pathway, which is responsible for cell migration, was activated by Arecoline treatment, and a decreased expression level of E-cadherin, which is an epithelial marker, was observed in Arecoline-treated cell lines. Blockade of the EGFR/c-Src/Fak pathway with the inhibitors of EGFR (Gefitinib) or c-Src (Dasatinib) significantly prevented Arecoline-promoted migration in A549 cells. Gefitinib or Dasatinib treatment significantly disrupted the Arecoline-induced localization of phospho-Y576-Fak during focal adhesion in A549 cells. Interestingly, Arecoline-promoted migration in A549 cells was blocked by a specific mAChR3 inhibitor (4-DAMP) or a neutralizing antibody of matrix metalloproteinase (MMP7 or Matrilysin). Taken together, our findings suggest that mAChR3 might play an essential role in Arecoline-promoted EGFR/c-Src/Fak activation and migration in an A549 lung cancer cell line.</jats:p> Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway Toxins |
| spellingShingle | Chang, Chih-Hsiang, Chen, Mei-Chih, Chiu, Te-Huan, Li, Yu-Hsuan, Yu, Wan-Chen, Liao, Wan-Ling, Oner, Muhammet, Yu, Chang-Tze, Wu, Chun-Chi, Yang, Tsung-Ying, Teng, Chieh-Lin, Chiu, Kun-Yuan, Chen, Kun-Chien, Wang, Hsin-Yi, Yue, Chia-Herng, Lai, Chih-Ho, Hsieh, Jer-Tsong, Lin, Ho, Toxins, Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway, Health, Toxicology and Mutagenesis, Toxicology |
| title | Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_full | Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_fullStr | Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_full_unstemmed | Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_short | Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| title_sort | arecoline promotes migration of a549 lung cancer cells through activating the egfr/src/fak pathway |
| title_unstemmed | Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway |
| topic | Health, Toxicology and Mutagenesis, Toxicology |
| url | http://dx.doi.org/10.3390/toxins11040185 |